ReviewThoracic cancer2025
A Case of Pulmonary Basaloid Squamous Cell Carcinoma in a Non-Smoking Female: Case Report and Literature Review.
Review in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary basaloid squamous cell carcinoma (BSCC) is a rare, high-grade subtype of lung squamous cell carcinoma. It predominantly affects elderly male smokers and is usually diagnosed at an advanced stage. Here, we report an early-stage BSCC in a 67-year-old non-smoking female identified during routine health screening. Chest CT revealed a 30-mm mass in the right lower lobe. PET-CT showed mild FDG uptake without lymph node or distant metastasis. Bronchoscopy confirmed malignancy, and thoracoscopic lobectomy with mediastinal lymph node dissection was performed. Gross pathology demonstrated a polypoid tumor protruding into the bronchial lumen. Histologically, the tumor exhibited solid basaloid nests with peripheral palisading and a high nuclear-to-cytoplasmic ratio. Immunohistochemistry showed strong p63 and CK5/6 positivity, with weak focal p40 expression in less than 20% of tumor cells. Ki-67 labeling index was approximately 50%. Neuroendocrine and breast cancer markers were negative. Mosaic p53 positivity was observed, and no actionable mutations were identified via next-generation sequencing. The final diagnosis was primary pulmonary BSCC (pT1cN0M0, Stage IA3). The patient remains recurrence-free 18 months postoperatively without adjuvant therapy. A literature review of 11 representative reports revealed BSCC typically presents in older male smokers at later stages and carries a poor prognosis. This case highlights the potential for BSCC to occur in non-smokers and at early stages, emphasizing the importance of a multidisciplinary diagnostic approach integrating histology, immunohistochemistry, and molecular data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.